BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gopal R, Selvarasu K, Pandian PP, Ganesan K. Integrative transcriptome analysis of liver cancer profiles identifies upstream regulators and clinical significance of ACSM3 gene expression. Cell Oncol (Dordr) 2017;40:219-33. [PMID: 28390038 DOI: 10.1007/s13402-017-0321-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Sun W, Ren W, Zhang J, Xu G. Predicting Panel of Metabolism and Immune-Related Genes for the Prognosis of Human Ovarian Cancer. Front Cell Dev Biol 2021;9:690542. [PMID: 34322485 DOI: 10.3389/fcell.2021.690542] [Reference Citation Analysis]
2 Miyake K, Kawaguchi A, Miura R, Kobayashi S, Tran NQV, Kobayashi S, Miyashita C, Araki A, Kubota T, Yamagata Z, Kishi R. Association between DNA methylation in cord blood and maternal smoking: The Hokkaido Study on Environment and Children's Health. Sci Rep 2018;8:5654. [PMID: 29618728 DOI: 10.1038/s41598-018-23772-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
3 Junková K, Mirchi LF, Chylíková B, Janků M, Šilhavý J, Hüttl M, Marková I, Miklánková D, Včelák J, Malínská H, Pravenec M, Šeda O, Liška F. Hepatic Transcriptome Profiling Reveals Lack of Acsm3 Expression in Polydactylous Rats with High-Fat Diet-Induced Hypertriglyceridemia and Visceral Fat Accumulation. Nutrients 2021;13:1462. [PMID: 33923085 DOI: 10.3390/nu13051462] [Reference Citation Analysis]
4 Yan L, He Z, Li W, Liu N, Gao S. The Overexpression of Acyl-CoA Medium-Chain Synthetase-3 (ACSM3) Suppresses the Ovarian Cancer Progression via the Inhibition of Integrin β1/AKT Signaling Pathway. Front Oncol 2021;11:644840. [PMID: 33869039 DOI: 10.3389/fonc.2021.644840] [Reference Citation Analysis]
5 Honda T, Rahman MA. Profiling of LINE-1-Related Genes in Hepatocellular Carcinoma. Int J Mol Sci 2019;20:E645. [PMID: 30717368 DOI: 10.3390/ijms20030645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Cheng Y, Yin B, Hou T, Chen T, Ping J. The overexpression of GRASP might inhibit cell proliferation and invasion in hepatocellular carcinoma. J Cell Physiol 2019. [PMID: 30779348 DOI: 10.1002/jcp.28285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
7 Zahid KR, Han S, Zhou F, Raza U. Novel tumor suppressor SPRYD4 inhibits tumor progression in hepatocellular carcinoma by inducing apoptotic cell death. Cell Oncol (Dordr) 2019;42:55-66. [PMID: 30238408 DOI: 10.1007/s13402-018-0407-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
8 Gallolu Kankanamalage S, Karra AS, Cobb MH. WNK pathways in cancer signaling networks. Cell Commun Signal 2018;16:72. [PMID: 30390653 DOI: 10.1186/s12964-018-0287-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
9 D'Alessandro R, Refolo MG, Lippolis C, Carella N, Messa C, Cavallini A, Carr BI. Strong enhancement by IGF1-R antagonists of hepatocellular carcinoma cell migration inhibition by Sorafenib and/or vitamin K1. Cell Oncol (Dordr) 2018;41:283-96. [PMID: 29470830 DOI: 10.1007/s13402-018-0370-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
10 Zhu Z, Wang D, Shen Y. Loss of ACSM3 confers worsened prognosis and immune exclusion to cutaneous melanoma. J Cancer 2020;11:6582-90. [PMID: 33046979 DOI: 10.7150/jca.48354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]